PATENT CLAIM ANALYSIS

Application Number: 16242336
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "081000"]

Abstract:
Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.

Claim (Index 8):
The method of  claim 1 , wherein the human papillomavirus is type 18.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 99.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14854897', '15718898', '15171935', '15758328', '14211002']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7762678412839673
- 35 USC 102 Novelty (BERT): 0.5483997734840705
- Combined Prediction Score: 0.7534810345039776
- Mean Citation Score: 350.975684
- Max Citation Score: 396.6942
- Similarity Product: 259.6957999961615

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test